Domainex is an award-winning integrated drug discovery services provider. In recent years we have been recognised by a range of industry bodies, celebrating our success as a team and as a business.
Domainex has received a King’s Award for Enterprise: International Trade 2023. This prestigious award recognises the company’s outstanding growth in international trade over three years (2019-2021) which amounted to a more than one hundred per cent increase in international revenues during the period.
Domainex was awarded Gold for High Growth Business of the Year and Silver for Business of the Year (>50 employees).
Business Weekly Awards
Domainex was honoured to receive the Life Sciences Scale-up Award 2023.
Domainex has been awarded the Best Drug Development, Discovery and Contract Research Organisation, 2022 - United Kingdom at the Global Health and Pharma Global Excellence Awards.
Following success in the Cambridge regional awards, Domainex went on to win the Silver award for High Growth in the National Awards.
Domainex was awarded a Gold award for High Growth Business of the Year and a Silver award for Business of the Year (more than 50 employees).
Domainex has been awarded the Leading Providers of Integrated Drug Delivery Services 2022 in the Global Health and Pharma International Life Sciences Awards.
Domainex has been awarded the Most Innovative Drug Discovery CRO 2022 in the Healthcare and Pharmaceutical Awards, gaining recognition for the third year in a row.
Domainex has been awarded the Best Drug Discovery CRO 2021 in the Healthcare and Pharmaceutical Awards 2021. After our success in 2020, Global Health & Pharma’s team of judges have recognised our services in this sector for the second year running.
Our Bioscience lab won a 2021 Freezer Challenge award, saving 48 kWh/day! The challenge is designed to encourage labs to optimise the sustainability of cold storage management and help change practices for the benefit of our environment.
We were named the Best CRO at the postponed OBN Awards 2020, awarded in June 2021. Following a very challenging period during the pandemic, the judges recognised our customer focus and the award would not have been possible without the hard work of our fantastic team. This is what allows Domainex to offer high quality services and remain a leader in the field of drug discovery.
At the Healthcare & Pharmaceutical Awards 2020, hosted by Global Health & Pharma (GHP), Domainex was awarded Drug Discovery CRO of the Year – Europe, recognising Domainex’s contribution to the industry and reflecting our expertise in drug discovery, dedication to customer service and commitment to promoting excellence.
Domainex was ranked within the top 1000 fastest growing companies in Europe by the Financial Times in 2018. We were the only drug discovery CRO to have made this list.